FEM1A and colitis: To determine whether EPRAP alters anti-inflammatory functions of EP4 signaling in vivo, we examined the pharmacological effects of ONO-AE1-329, a selective EP4 agonist, in DSS-induced colitis of WT and EPRAP-deficient mice.